As far as I understand, viruses tend to be only resistant in one direction: either antibiotics or phages, but they can't be resistant to both.
In the 2010s there were a lot of public talks at the DKFZ (German cancer research center) where research teams were looking for getting more attention and funds for that area, but I have no clue what happened to that.
Sars-cov-2 was kind of the prime example of a virus that you can't beat with antibiotics, so I was assuming that every pharma company would now direct their research at bacteriophage research...but there's not much information about it as far as I can tell.
Anyone have some interesting papers on that?